Startseite>>Signaling Pathways>> GPCR/G protein>> mAChR>>Sofpironium bromide

Sofpironium bromide (Synonyms: BBI 4000)

Katalog-Nr.GC63196

Sofpironiumbromid (BBI 4000) ist ein Anticholinergikum, das zur Untersuchung der primÄren axillÄren Hyperhidrose (PAH) verwendet wird.

Products are for research use only. Not for human use. We do not sell to patients.

Sofpironium bromide Chemische Struktur

Cas No.: 1628106-94-4

Größe Preis Lagerbestand Menge
1mg
63,00 $
Auf Lager
5mg
140,00 $
Auf Lager
10mg
224,00 $
Auf Lager
25mg
403,00 $
Auf Lager
50mg
605,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com


Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Sofpironium bromide (BBI 4000) is an anticholinergic agent used in the study of primary axillary hyperhidrosis (PAH). Sofpironium bromide reduces sweating by inhibiting M3 muscarinic receptors in eccrine glands at the application site. Sofpironium bromide also has a high afnity for the M1, M2, M4 and M5 subtypes[1].

Sofpironium bromide is metabolized mainly through non-enzymatic hydrolysis, and also through oxidative metabolism via CYP2D6 and CYP3A4[1].

Sofpironium bromide exhibits anticholinergic activity by inhibiting the contractile activity of guinea pig ileal tissue in a concentration-dependent manner. In a rat model, Sofpironium bromide reduces footpad sweating induced by Pilocarpine (a muscarinic receptor agonist)[1].

[1]. Julia Paik, et al. Sofpironium Bromide: First Approval. Drugs. 2020 Dec;80(18):1981-1986.

Bewertungen

Review for Sofpironium bromide

Average Rating: 5 ★★★★★ (Based on Reviews and 1 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Sofpironium bromide

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.